Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03837457
Title PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study (PRISM)
Acronym PRISM
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors miRagen Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | BEL

Facility Status City State Zip Country Details
Mayo Clinic Hospital Phoenix Arizona 85054 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University School of Medicine Saint Louis Missouri 63108 United States Details
The Ohio State University and Wexner Medical Center Columbus Ohio 43210 United States Details
University of Washington/Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
University Hospital Leuven Leuven B3000 Belgium Details
Hopital Saint Andre, CHU de Bordeaux Bordeaux 33076 France Details
Hopital Saint-Louis Paris 75475 France Details
Hopital Charles Nicolle, CHU de Rouen Rouen 76031 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field